Literature DB >> 4147246

Comparison of propranolol and Ro 3-3528 in hyperthyroid tachycardia and dysrhythmias.

E M Phillips, P Turner, J Houghton, D G Ferriman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4147246      PMCID: PMC2495364          DOI: 10.1136/pgmj.49.567.18

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  12 in total

1.  PHARMACODYNAMIC EFFECTS OF BETA-ADRENERGIC RECEPTOR BLOCKADE IN PATIENTS WITH HYPERTHYROIDISM.

Authors:  W R WILSON; E O THEILEN; F W FLETCHER
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  CATECHOLAMINE DEPLETION IN THYROTOXICOSIS. EFFECT OF GUANETHIDINE ON CARDIOVASCULAR DYNAMICS.

Authors:  S GOLDSTEIN; T KILLIP
Journal:  Circulation       Date:  1965-02       Impact factor: 29.690

3.  Effects of oral and intramuscular administration of reserpine in thyrotoxicosis.

Authors:  J J CANARY; M SCHAAF; B J DUFFY; L H KYLE
Journal:  N Engl J Med       Date:  1957-09-05       Impact factor: 91.245

4.  Effect of variation in thyroid function on the pressor response to norepinephrine in man.

Authors:  R E SCHNECKLOTH; G S KURLAND; A S FREEDBERG
Journal:  Metabolism       Date:  1953-11       Impact factor: 8.694

5.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

6.  A comparison of three beta-adrenergic receptor-blocking drugs in thyrotoxic tachycardia.

Authors:  P Turner; R C Hill
Journal:  J Clin Pharmacol J New Drugs       Date:  1968 Jul-Aug

7.  Proceedings: Preliminary studies of Ro 3-3528, a beta-adrenoceptor-blocking agent, in man.

Authors:  D C Hicks; E M Phillips
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

8.  Some pharmacological actions of the beta-adrenolytic agent Ro 3-3528 (6,7-dimethyl-alpha-[(isopropylamino) methyl]-2-benzofuranmethanol Hydrochloride).

Authors:  W Haefely; A Hürlimann; H Thoenen
Journal:  Angiologica       Date:  1967

9.  Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.

Authors:  J M Kofi Ekue; D C Lowe; R G Shanks
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

10.  Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.

Authors:  J D Fitzgerald; S R O'Donnell
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

View more
  3 in total

1.  Ro 3-4787, a new β-adrenoceptor blocking agent: Studies in normal volunteers.

Authors:  J R Kilborn; P Turner
Journal:  Br J Clin Pharmacol       Date:  1974-04       Impact factor: 4.335

Review 2.  Beta-adrenergic receptor blocking drugs in hyperthyroidism.

Authors:  P Turner
Journal:  Drugs       Date:  1974       Impact factor: 9.546

3.  The assessment of β-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  S G Carruthers; A Ghosal; D G McDevitt; J K Nelson; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1974-04       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.